Beam Therapeutics BEAM Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$94.32M+12.9% | —— | -$112.73M-16.6% | -$103.23M-13.4% | -$108.33M-9.8% | ||
| $5.61M+1.4% | $5.67M+4.1% | $5.56M+1.6% | $5.54M-0.7% | $5.53M+1.8% | ||
| $19.04M-28.6% | $20.45M-32.3% | $22.75M-23.0% | $24.37M-22.9% | $26.68M-8.9% | ||
| -$128.51M-23.7% | -$83.29M-9.1% | -$81.48M+7.5% | -$76.45M+7.9% | -$103.88M-4.1% | ||
| $2.23M-27.2% | $3.73M+25.7% | $5.01M+218% | $3.14M+59.9% | $3.07M+25.7% | ||
| $25.27M+120% | —— | —— | -$170.41M-295% | -$125.09M-134% | ||
| $93.89M— | —— | —— | —— | $0— | ||
| $96.61M-79.6% | $1.89M-45.2% | $1.68M+32.7% | $1.11M+734% | $473.38M+16,240% | ||
| -$6.64M-103% | $27M— | -$14.15M+77.2% | -$245.75M— | $244.41M+263% | ||
| -$130.75M-22.2% | -$87.02M-9.7% | -$86.49M+3.6% | -$79.59M+6.3% | -$106.95M-4.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Beam Therapeutics generate?
- Beam Therapeutics (BEAM) generated -$369.7M in operating cash flow over the trailing twelve months.
- What is Beam Therapeutics's free cash flow?
- After $14.1M of capital expenditures, Beam Therapeutics's free cash flow was -$383.8M over the trailing twelve months, down 6.3% year over year.
- Where does Beam Therapeutics's cash flow data come from?
- Every line is extracted from Beam Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
